Figure 4From: Characterization of CDKN2A(p16) methylation and impact in colorectal cancer: systematic analysis using pyrosequencing Kaplan-Meier survival curves showing the unfavorable prognostic impact of CDKN2A methylation positivity in (A) all patients and in cases with (B) microsatellite stable (MSS/MSI-L), (C) microsatellite instability-high (MSI-H), (D) BRAF wild-type (WT) and (E) BRAF mutation. Back to article page